主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ENGN
#2490
enGene Holdings Inc. Common Stock
10.110
0
+0.20%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.20%
每月变动
-9.25%
6个月变化
+20.36%
年变化
+20.36%
前一天收盘价
10.090
0
Open
10.110
0
Bid
Ask
Low
10.110
0
High
10.110
0
交易量
9
市场
股票
医疗保健
ENGN
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
2025
TTM
Key stats
Total common shares outstanding
23.2 M
50.98 M
66.98 M
—
Valuation ratios
Enterprise value
382.44 M
278.14 M
432.76 M
1.03 B
Price to earnings ratio
0.13
6.06
3.15
12.28
Price to sales ratio
3.87
848.66
122.86 K
146.96 K
Price to cash flow ratio
0.56
6.92
3.72
12.51
Price to book ratio
0.19
1.23
2.2
2.86
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
1.15
0.18
0.53
0.47
Return on equity %
1.38
0.2
0.7
0.58
Return on invested capital %
3 669.8
660.95
879.54
892.76
Gross margin %
100
100
100
400
Operating margin %
727.93
15.81 K
4.11 M
265.26 K
EBITDA margin %
—
—
—
—
Net margin %
2 790.98
14 K
3.91 M
257.65 K
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
16.25
16.87
6.3
46.46
Inventory turnover
—
—
—
—
Asset turnover
0.04
0
0
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
0.11
0.07
0.07
0.29
Long term debt to total equity ratio
0.13
0.08
0.09
0.35
Per share metrics
Operating cash flow per share
35.66
1.28
1.94
1.94
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
117.7
6.31
3.79
16.2
Net current asset value per share
123.36
6.55
3.94
16.91
Tangible book value per share
104.66
7.22
3.28
16.57
Working capital per share
115.77
6.16
3.31
15.28
Book value per share
104.66
7.22
3.28
16.57
新闻
根据摩根士丹利:值得关注的顶级中小市值生物科技股票
Top SMID Cap Biotech Stocks to Watch According to Morgan Stanley
3 Best Stocks to Buy Today, 1/30/2026, According to Top Analysts - TipRanks.com
Jefferies 以买入评级开始对 Engene 股票的覆盖
Jefferies initiates coverage on Engene stock with Buy rating
enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 (NASDAQ:ENGN)
Citizens重申Engene股票市场表现优于大盘评级,目标价21美元
Citizens reiterates Market Outperform rating on Engene stock with $21 target
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
H.C. Wainwright 重申 Engene 股票为"买入"评级,看好其膀胱癌治疗优势
Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages
CG Oncology Undervalued Going Into A Busy 2026 (NASDAQ:CGON)